Medicare AdvantageCoverageMedium impact
MA11.014g, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
Independence Blue Cross·Podiatry·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Summary
Policy MA11.014g regarding debridement of mycotic and symptomatic non-mycotic hypertrophic toe nails was reissued effective April 2, 2025. This recent update (1 month old) affects Medicare Advantage coverage and billing for nail debridement procedures. The billing team must review the full policy text to identify any changes to coverage criteria, billing codes, prior authorization requirements, or documentation standards compared to the previous version.
Action Required
By April 16, 2025 (deadline for Medicare Advantage plan implementation): Billing team must obtain and review the complete MA11.014g policy text from the provided URL to identify all specific CPT, HCPCS, and ICD-10 codes affected by this reissue. Update billing system rules, prior authorization workflows, and provider documentation templates accordingly. Notify podiatry providers and front desk staff of any changes to coverage, authorization requirements, or medical necessity documentation. Confirm all claims for nail debridement procedures submitted after April 2, 2025 comply with the reissued policy requirements. Failure to implement changes may result in claim denials for non-compliant submissions.